Exparel
402-C-333
Phase 3 small_molecule completed
Quick answer
Exparel for Lower Extremity Surgery is a Phase 3 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Lower Extremity Surgery
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed